Why the study?
Does the Glasgow prognostic score (GPS) predict patient survival following oesophageal and gastric resections for malignant disease?
Does the Glasgow prognostic score (GPS) predict patient survival following oesophageal and gastric resections for malignant disease?
A Glasgow prognostic score of 2 predicts poor survival and more advanced tumors in patients undergoing oesophageal and gastric resections for malignant disease, suggesting they may not derive benefit from surgical resection.
GPS 2 may signal limited resection benefit in upper GI malignancy; leaves open prospective validation before guiding surgical selection.
No takes yet. Share an insight, caveat, or question.
Halter et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: